How India’s COVID Surge is Fueling the Vaccine Diplomacy Debate
How India’s COVID Surge is Fueling the Vaccine Diplomacy Debate

Who gets to decide which country gets which vaccine?

COVID ward inside a banquet hall, on April 29, 2021 (Tauseef Mystafa, Getty Images)

COVID ward inside a banquet hall, on April 29, 2021 (Tauseef Mystafa, Getty Images)

Earlier this week, after a weekend of deliberations with Indian officials, the U.S. announced a host of COVID-19 assistance to the country. The announcement comes after mounting pressure from the Indian public, the head of the Serum Institute of India — the world’s largest vaccine maker — and the Indian American diaspora. In a briefing on April 27, U.S. President Joe Biden said the U.S. would send remdesivir, PPE, and other supplies that facilitate COVID recovery, redirect one of its own orders of AstraZeneca manufacturing components, and supply prepared doses of the Oxford-AstraZeneca vaccine to India. A White House press briefing stated, “We remember India’s generosity to the United States in the early days of the pandemic, when India offered medications to us as our hospitals were strained. And the U.S. and India have been partners on global health for seven decades.”

Get access to this article and many more at The Juggernaut. No ads, no clickbait — just smart writing.

logo

The Juggernaut tells untold, smart South Asian stories and news you won't find anywhere else.

The Weekly

It’s like your other email briefings. But browner. Join thousands and get the best newsletter that curates the global news on South Asia(ns) every Sunday. We also send updates on events, giveaways, our original reporting, and more. Unsubscribe anytime.

Categories

Business & TechCrosswordCultureEditor's PicksFictionFilm & TVFoodOpinionPoliticsScience & TechnologySports
© 2021 THE JUGGERNAUT® ALL RIGHTS RESERVED.
Privacy PolicyTerms of Use